Cargando…
Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791202/ https://www.ncbi.nlm.nih.gov/pubmed/33437814 http://dx.doi.org/10.21037/atm-20-3243 |
| _version_ | 1783633560142348288 |
|---|---|
| author | Sgalla, Giacomo Mari, Pier-Valerio Richeldi, Luca |
| author_facet | Sgalla, Giacomo Mari, Pier-Valerio Richeldi, Luca |
| author_sort | Sgalla, Giacomo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7791202 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77912022021-01-11 Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t Sgalla, Giacomo Mari, Pier-Valerio Richeldi, Luca Ann Transl Med Editorial Commentary AME Publishing Company 2020-12 /pmc/articles/PMC7791202/ /pubmed/33437814 http://dx.doi.org/10.21037/atm-20-3243 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Sgalla, Giacomo Mari, Pier-Valerio Richeldi, Luca Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title | Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title_full | Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title_fullStr | Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title_full_unstemmed | Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title_short | Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| title_sort | home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791202/ https://www.ncbi.nlm.nih.gov/pubmed/33437814 http://dx.doi.org/10.21037/atm-20-3243 |
| work_keys_str_mv | AT sgallagiacomo homespirometrytoassessefficacyofpirfenidoneinprogressiveunclassifiableinterstitiallungdiseasebetterthedevilyouknowthanthedevilyoudont AT maripiervalerio homespirometrytoassessefficacyofpirfenidoneinprogressiveunclassifiableinterstitiallungdiseasebetterthedevilyouknowthanthedevilyoudont AT richeldiluca homespirometrytoassessefficacyofpirfenidoneinprogressiveunclassifiableinterstitiallungdiseasebetterthedevilyouknowthanthedevilyoudont |